Stage IB2 cervical cancer: A decision analysis comparing quality-adjusted survival associated with chemoradiation versus radical surgery with tailored adjuvant chemoradiation

被引：1
|
作者：
Einstein, M. [1 ]
Hollenberg, J. [2 ]
Hartenbach, E. [1 ]
Chappell, R. [1 ]
Kushner, D. [1 ]
Evans, A. [1 ]
Connor, J. [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
来源：
GYNECOLOGIC ONCOLOGY | 2011年 / 121卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2010.12.071
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
64
引用
收藏
页码：S28 / S29
页数：2
相关论文
共 50 条
  • [1] Comparison of Neoadjuvant Chemotherapy Followed by Radical Surgery with Chemoradiation in Stage IB2 to IIB of Cervical Cancer
    Arab, Maliheh
    Hadi, Fatemeh
    Raoufi, Masoomeh
    Anbiaee, Robab
    Teymoordash, Somayyeh Noei
    Hosseini, Maryam Sadat
    Farzaneh, Farah
    Talayeh, Maryam
    Ganjouee, Tahereh Ashraf
    Azghandi, Samira
    Moridi, Atefeh
    Rooy, Rezvaneh Sadat Beheshti
    Amiri, Fatemeh
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2024, 17 (01)
  • [2] The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer
    Morice, P.
    Uzan, C.
    Zafrani, Y.
    Delpech, Y.
    Gouy, S.
    Haie-Meder, C.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (01) : S122 - S124
  • [3] Comparison of radical hysterectomy with chemoradiation therapy for stage IB2 and IIA2 cervical cancer
    Park, J.
    Kim, J.
    Park, S.
    Nam, J.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S19 - S20
  • [4] Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer
    Park, Jeong-Yeol
    Kim, Dae-Yeon
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Kim, Young-Seok
    Kim, Ha Jeong
    Lee, Jeong-Won
    Kim, Byoung-Gie
    Bae, Duk-Soo
    Huh, Seung Jae
    Nam, Joo-Hyun
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2012, 23 (04) : 226 - 234
  • [5] Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: A cost effectiveness analysis
    Jewell, Elizabeth L.
    Kulasingam, Shalini
    Myers, Evan R.
    Secord, Angeles Alvarez
    Havrilesky, Laura J.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (03) : 532 - 540
  • [6] Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: A comparison of complications for open versus minimally invasive surgery
    Miller, H.
    Hom, M. S.
    Castaneda, A.
    Matsuo, K.
    Roman, L. D.
    Brunette, L. L.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 202 - 202
  • [7] Surgery versus radiation therapy for stage IB2 cervical carcinoma: A population-based outcome analysis in the era of chemoradiation
    Courtney-Brooks, M.
    Rungruang, B.
    Beriwal, S.
    Zorn, K.
    Richard, S.
    Sukumvanich, P.
    Olawaiye, A.
    Krivak, T.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S20 - S21
  • [8] Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery
    Miller, Heather
    Matsuo, Koji M.
    Roman, Lynda D.
    Yessaian, Annie A.
    Pham, Huyen Q.
    Hom, Marianne
    Castaneda, Antonio
    Pham, Anthony
    Ragab, Omar
    Muderspach, Laila
    Ciccone, Marcia
    Brunette, Laurie L.
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [9] Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery
    Heather Miller
    Koji Matsuo
    Lynda D. Roman
    Annie A. Yessaian
    Huyen Q. Pham
    Marianne Hom
    Antonio Castaneda
    Anthony Pham
    Omar Ragab
    Laila Muderspach
    Marcia Ciccone
    Laurie L. Brunette
    Radiation Oncology, 16
  • [10] Chemoradiation versus neoadjuvant chemoradiation followed by radical surgery for FIGO stage III cervical cancer: Analysis of complications and 3-year survival
    Fanfani, F.
    Monterossi, G.
    Vizza, E.
    Landoni, F.
    De Iaco, P.
    Corrado, G.
    Colangione, S.
    Perrone, A. M.
    Scambia, G.
    Fagotti, A.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 30 - 30
12345